A recent study of lung, prostate or breast cancer patients found that after 6 months, 70% of patients who received laser surgery achieved complete healing, compared to 40% of patients who received conventional surgery.
According to an article published by Myelomabeacon.Com, a small Turkish study indicates that laser surgery may be a viable treatment option or cancer patients who experience bisphosphonate-related bone death in their jaws.
“Patients who received laser surgery achieved higher rates of complete healing than patients who received conventional surgery,” (Myeloma Beacon).Bisphosphonates, such as Aredia- also known as zoledronic acid, and Zometa- parmidronate, are a class of drugs frequently administered to myeloma patients with bone disease to “slow the breakdown of bone and help prevent fractures,” (Myeloma Beacon). These drugs have been shown to cause osteonecrosis, a condition characterized by the death of jawbone tissue by inhibiting the development of blood vessels in the bone.
Dr. Belir Atalay of Istanbul University in Turkey and the lead author of the study says “laser surgery may be a better treatment option for these patients then conventional surgery.”
In the study, all patients had received intravenous Zometa as part of their cancer treatment before developing bone death in their jaws. Half of the patients were randomly placed into either the laser surgery or conventional surgery treatment groups.
The findings were amusing. “70% of patients who received laser surgery achieved complete healing, which the researches defined as full covering of the exposed bone with no signs of infection, compared to 40% of patients who received conventional surgery,” (Myeloma Beacon).
Bone death in the jaw is a serious ailment that affects people around the world, especially cancer patients. Consider laser surgery as opposed to conventional surgery when seeking treatment. Although the results of this study are suggestive, the study was small and the difference in rates is not considered significant. For the full article, click here.
For information on Tropicalaser Franchise, click here.
No comments:
Post a Comment